Core Viewpoint - The U.S. Food and Drug Administration (FDA) has issued warning letters to four major retailers for selling baby formula associated with a bacterial illness outbreak in infants, despite prior advisories [1] Group 1: Regulatory Actions - The FDA's warning letters highlight ongoing concerns regarding the safety of baby formula products in the market [1] - The retailers involved have been identified as continuing to sell products linked to the outbreak, raising questions about compliance with health regulations [1] Group 2: Health Implications - The bacterial illness outbreak has significant implications for infant health, necessitating immediate action from both retailers and regulatory bodies [1] - The situation underscores the importance of stringent safety measures in the baby formula industry to protect vulnerable populations [1]
US FDA sends warning letters to Walmart, Target for selling recalled baby formula